Autopsy report · NCT02311088

Trial of Caffeine to Alleviate Dyspnea Related to Ticagrelor

“Too low enrolment rate”

The sponsor’s own words in the registry.

Life of this trial

• 26 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Uppsala University

Sponsor type

University, hospital or other

Conditions

Dyspnea

Interventions

Caffeine; Placebo

Participants

26

Sites

9

Countries

Sweden

Trials that died the same way

• Evaluation of ATRA Activity in Combination With Anastrozole in Pre-operative Phase of Operable Early Breast Cancer
  “Low enrolment rate” (93% match in meaning)
• A Study of Treprostinil Palmitil Inhalation Powder (TPIP) In Pulmonary Arterial Hypertension (PAH)
  “Low enrolment” (84% match in meaning)
• Safety and Efficacy Trial to Treat Diastolic Heart Failure Using Ambrisentan
  “Poor enrolment” (77% match in meaning)
• Sorafenib in First-line Treatment of Advanced B Child Hepatocellular Carcinoma
  “lack of enrolment” (77% match in meaning)
• Study on Performance and Safety of Sentinox in the Prevention of Acute Respiratory Infections (ARI)
  “Difficulty in enrolment” (73% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.